Aggreguide a-100
WebAggreDyne Diagnostic Device, Platelet Function Monitoring Houston, TX 1 2 3 AggreGuide A-100 Simple, reliable, low-cost system for the assessment of platelet … WebMay 16, 2012 · Published: May 16, 2012 HOUSTON-- (BUSINESS WIRE)--Aggredyne, Inc. (www.aggredyne.com), a Houston-based biomedical diagnostics company that is defining a new standard for platelet function testing, has received the CE Mark approval for its AggreGuide A-100 blood platelet testing system.
Aggreguide a-100
Did you know?
WebJul 1, 2024 · • AggreGuide A-100 ADP assay is a nov el assay for meas- uring the antiplatelet response to platelet P2Y 12 inhibitors by detecting platelet aggregates in … WebAggreGuide A-100. 1. Company making the submission: Name: Aggredyne, Inc. Address: 10530 Rockley Road Suite 150 Houston, Texas 77099 Telephone. 713-636-5996 Toll …
WebApr 12, 2024 · Pivotal Study of the AggreGuide A-100 Adenosine Diphosphate (ADP) Assay to Evaluate the Detection of Platelet Dysfunction Due to P2Y12 Antiplatelet Drugs: Actual … WebApr 14, 2014 · Cohort. Time Perspective: Prospective. Official Title: Pivotal Study of the AggreGuide A-100 Adenosine Diphosphate (ADP) Assay to Evaluate the Effect of ADP Blocking Drugs on Platelet Aggregation on the AggreGuide A-100 Instrument. Study Start Date : March 2014. Actual Primary Completion Date :
WebJan 8, 2014 · Houston-based biomedical company Aggredyne received FDA clearance to market its AggreGuide A-100, first step toward providing total platelet testing and … WebApr 8, 2024 · HOUSTON, April 8, 2024 /PRNewswire/ -- Platelet testing and research company Aggredyne, Inc. has received U.S. Food and Drug Administration (FDA) clearance for its unique AggreGuide A‑100® ADP ...
WebClinical validation of AggreGuide A-100 ADP, a novel assay for assessing the antiplatelet effect of oral P2Y12 antagonists. Article. Publisher preview available. Journal of Thrombosis and ...
WebJun 18, 2024 · AggreGuide A-100 ADP assay is a novel assay for measuring the antiplatelet response to platelet P2Y 12 inhibitors by detecting platelet aggregates in whole blood … projects fit cvutWebAug 1, 2013 · The AggreGuide A-100 (Aggredyne Inc, Houston, TX; Figure 1) is a new, easy-to-use platelet aggregometer developed to monitor platelet aggregation in whole … projects finnish homesWebThe AggreGuide A-100 AA Assay is a qualitative system to aid in the detection of platelet dysfunction due to aspirin ingestion by those 18 years of age or older in 3.2% citrated venous whole blood using the AggreGuide A-100 instrument. For professional use. This test is not for use in patients with underlying congenital platelet abnormalities ... projects fivethirtyeight footballWebApr 9, 2024 · According to the company, its AggreGuide A-100 ADP Assay testing cartridge is a cost-effective in vitro diagnostic device that is used to measure the effect of various antiplatelet medications that target the platelet P2Y12 receptor. Following the US FDA clearance, the company said it plans to market labchip gx ii touch 24WebMay 16, 2012 · Published: May 16, 2012. HOUSTON-- (BUSINESS WIRE)--Aggredyne, Inc. (www.aggredyne.com), a Houston-based biomedical diagnostics company that is … labchip method developmentWebAggreguide A-100 ADP Assay Evaluation : Official Title: Pivotal Study of the AggreGuide A-100 Adenosine Diphosphate (ADP) Assay to Evaluate the Effect of ADP Blocking Drugs on Platelet Aggregation on the AggreGuide A-100 Instrument : Secondary IDs: Study Status. Record Verification: April 2024 projects fivethirtyeightWebJan 8, 2014 · The AggreGuide A-100, manufactured at Aggredyne’s ISO 13485 certified U.S. facility, is already CE marked and marketed internationally. ... projects finance